CMS Competitive Bidding Hurts Medicare Beneficiaries With Diabetes
Competitive bidding reduces access to diabetes supplies and increases mortality for Medicare patients.
Competitive bidding reduces access to diabetes supplies and increases mortality for Medicare patients.
Induced pluripotent stem cells offer a new way to study insulin resistance and other metabolic disorders in humans.
During the past 50 years, diabetes research and management has come a long way, although there is still work to be done.
Activity in certain brain regions of teenagers with type 1 diabetes was increased or decreased with hyperglycemia and hypoglycemia.
PE0139, a super long-acting basal insulin, and PB1023, a weekly GLP-1 receptor agonist, may lead to novel approach to treating diabetes.
Unsupervised closed loop insulin delivery is safe and feasible in the home setting in teens with type 1 diabetes.
Continuous glucose monitoring can reduce costs associated with diabetes and improve quality of life.
Adding lixisenatide to insulin glargine is comparable to other insulin regimens for controlling HbA1c in type 2 diabetes.
Adding liraglutide to insulin in a closed loop system may reduce postprandial hyperglycemia as well as insulin requirements, compared with insulin monotherapy.
Researchers will look at effects in people with longstanding disease,